Nanobiotix is a clinical-stage biotechnology company based in Paris, France. It develops nanoparticle-based approaches intended to improve the effectiveness of radiotherapy in cancer treatment. Its main programme uses hafnium oxide nanoparticles, given as an injectable product, to amplify the radiation dose inside tumour cells while sparing surrounding healthy tissue. The company works with hospital clinicians and research partners on studies in several tumour types, and it also pursues oncology programmes built on its nanoparticle platform.
Nanobiotix S.A trades under the code NANO on the Euronext Paris in France, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #260 of 625 on the Euronext Paris · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for France yet.
TrendFair
61/100
Mixed trend against its averages.
See the numbers →
Above 200-day average4.1%
From 52-week high-34.4%
MomentumStrong
72/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return-14.0%
6-month return6.8%
12-month, skipping last month118.3%
Stability (higher is calmer)Weak
19/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)75.1%
Worst drawdown, 1 year (smaller is calmer)-59.2%
LiquidityStrong
88/100
Trades actively.
See the numbers →
Avg daily value traded5.37M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for France when fundamentals data for this market is added. All France stocks.
52-wk range 13.10 – 47.66Daily closes, split-adjusted
Signals
50-day average28.72
200-day average29.09
Golden/death cross (60d)Death, 2 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.12
Technical summary
Daily
Bullish
10 bullish · 1 neutral · 5 bearish
Weekly
Bullish
8 bullish · 1 neutral · 3 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
23.28
Bullish
EMA 10
25.02
Bullish
SMA 20
22.91
Bullish
EMA 20
24.65
Bullish
SMA 50
28.72
Bullish
EMA 50
27.17
Bullish
SMA 100
30.82
Bearish
EMA 100
28.85
Bullish
SMA 200
29.09
Bullish
EMA 200
27.33
Bullish
Oscillators (daily)
RSI (14)
66.57
Neutral
MACD (12, 26)
-0.40
Bearish
Momentum (12)
42.66
Bullish
Stochastic %K (14)
96.10
Bearish
Williams %R (14)
-3.90
Bearish
CCI (20)
179.2
Bearish
Pivot points (classic, last session)
S3
25.53
S2
26.67
S1
28.49
Pivot
29.63
R1
31.45
R2
32.59
R3
34.41
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
